Autres langues Abbott Laboratories

Actions

ABT

US0028241000

Equipement, fournitures et distribution médicale

Marché Fermé - 22:01:38 05/10/2026 Varia. 5j. Varia. 1 janv.
100,10 USD +2,67% Graphique intraday de Abbott Laboratories -0,87% -20,11%

Autres langues

05/10 Abbott Laboratories Receives FDA Approval for New CardioMEMS HF System capabilities
05/10 Abbott Laboratories Receives FDA Approval to Include Interactive Features in CardioMEMS Heart Monitor
05/10 Abbott receives FDA approval for new CardioMEMS HF System capabilities that help patients engage in the care of their heart condition
02/10 Schwacher Arbeitsmarkt gibt Aktien Auftrieb
02/10 Afternoon Meeting: La debilidad del empleo impulsa a las bolsas
02/10 Weak Jobs Lead to Stronger Stocks
02/10 Grail's cancer blood test nears landmark FDA approval, but insurance coverage looms
02/10 Analystenempfehlungen: Adidas, Hensoldt, Lindt, Airbnb, Hewlett Packard, Nike…
02/10 Analyst recommendations: Airbnb, Hewlett Packard Enterprise, Fair Isaac, Nike…
30/09 Abbott Launches Simplescreen Crc Blood Test in the U.S
30/09 Abbott Launches SimpleScreen Blood Test for Colorectal Cancer
30/09 Abbott hosts conference call for third-quarter earnings
30/09 Abbott launches SimpleScreen™ CRC blood test, joining Cologuard Plus® in its colorectal cancer screening portfolio
25/09 Abbott Laboratories : Landmark study in people with Type 2 diabetes using basal insulin shows continuous glucose monitoring, including Abbott’s Libre technology, associated with lower risk of death and cardiovascular complications
24/09 US FDA advisers endorse Grail cancer test's benefits in key vote
23/09 Abbott and Berry Street team up on personalized nutrition tracking
23/09 US companies face rise in cyber attacks
23/09 Abbott and Berry Street Partner To Expand Personalized Nutrition Support For Consumers Seeking Better Metabolic Health
23/09 Abbott And Berry Street Partner To Expand Personalized Nutrition Support For Consumers Seeking Better Metabolic Health
21/09 Grail rallies as FDA staff flags no major concerns for multi-cancer test
18/09 Trinity Heart Experts First in the Quad Cities to Use New Afib Technology
17/09 Abbott Laboratories Declares Quarterly Dividend, Payable on Nov. 16, 2026
17/09 Abbott Laboratories Keeps Quarterly Dividend at $0.63 a Share, Payable Nov. 16 to Holders of Record on Oct. 15
17/09 Abbott declares 411th consecutive quarterly dividend
15/09 Abbott Announces First Canadian Use of Volt Pulsed Field Ablation System to Treat Atrial Fibrillation
Aucun résultat pour cette recherche